Cephalosporin C acylase
    5.
    发明授权
    Cephalosporin C acylase 失效
    头孢菌素C酰基转移酶

    公开(公告)号:US5320948A

    公开(公告)日:1994-06-14

    申请号:US935312

    申请日:1992-08-26

    CPC分类号: C12N9/80 C12P35/04

    摘要: A cephalosporin C acylase from Pseudomonas diminuta N-176 is characterized by its ability to catalyze the conversion of cephalosporin C, glutaryl 7-ACA, adipyl 7-ACA, succinyl 7-ACA, N-acetylcephalosporin, N-benzoylcephalosporin C and cephalothin into 7-aminocephalosporanic acid. The enzyme contains an .alpha.-subunit having a molecular weight of 26 kDA and a .beta.-subunit having a molecular weight of 58 kDa. A method for the recombinant production of the present cephalosporin C acylase in Escherichia coli is provided.

    摘要翻译: 来自假单胞菌N-176的头孢菌素C酰基转移酶的特征在于其能够催化头孢菌素C,戊二酰7-ACA,己二酰基7-ACA,琥珀酰基7-ACA,N-乙酰头孢菌素,N-苯甲酰头孢菌素C和头孢噻吩转化为7 - 氨基头孢烷酸。 该酶含有分子量为26kDA的α亚基和分子量为58kDa的β亚基。 提供了在大肠杆菌中重组生产本发明头孢菌素C酰基转移酶的方法。

    Novel Pd Marker for Histone Deacetylase Inhibitor
    7.
    发明申请
    Novel Pd Marker for Histone Deacetylase Inhibitor 审中-公开
    组蛋白脱乙酰酶抑制剂的新型Pd标记

    公开(公告)号:US20080076138A1

    公开(公告)日:2008-03-27

    申请号:US11664422

    申请日:2006-02-24

    IPC分类号: G01N33/53 C12Q1/02

    CPC分类号: C12N9/99 C12Q1/48 G01N33/502

    摘要: It is intended to provide a method for evaluating a pharmacological effect of a histone deacetylase (HDAC) inhibitor, comprising the steps of: (a) preparing a cell expressing CPSF5 protein; (b) contacting the cell with an HDAC inhibitor; (c) measuring the acetylation level of CPSF5 protein in the cell; and (d) comparing the acetylation level measured in the step (c) with the measured acetylation level of CPSF5 protein in a control cell that has not been contacted with the HDAC inhibitor.

    摘要翻译: 本发明旨在提供一种评价组蛋白脱乙酰酶(HDAC)抑制剂的药理作用的方法,包括以下步骤:(a)制备表达CPSF5蛋白的细胞; (b)使细胞与HDAC抑制剂接触; (c)测量细胞中CPSF5蛋白的乙酰化水平; 和(d)将步骤(c)中测量的乙酰化水平与未与HDAC抑制剂接触的对照细胞中测量的CPSF5蛋白的乙酰化水平进行比较。

    Method of selecting novel immunosuppressant
    8.
    发明申请
    Method of selecting novel immunosuppressant 审中-公开
    选择新型免疫抑制剂的方法

    公开(公告)号:US20070123452A1

    公开(公告)日:2007-05-31

    申请号:US10540546

    申请日:2003-12-26

    摘要: The present invention provides a method of selecting an IL-2 production inhibitor and/or an immunocyte proliferation inhibitor having low GATA-1 production inhibitory activity, which comprises measuring the HDAC4 and/or HDAC8 inhibitory activity of a test substance, and a method of selecting an immunosuppressant having low thrombocytopenic activity, which comprises measuring the HDAC4 and/or HDAC8 inhibitory activity of a test HDAC inhibitor.

    摘要翻译: 本发明提供了选择具有低GATA-1产生抑制活性的IL-2产生抑制剂和/或免疫细胞增殖抑制剂的方法,其包括测定被检物质的HDAC4和/或HDAC8抑制活性, 选择具有低血小板减少活性的免疫抑制剂,其包括测量HDAC抑制剂的HDAC4和/或HDAC8抑制活性。